Selected publications
-
Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: A RECORD-1 subgroup analysis.
British Journal of Cancer.
2012
Academic Article
GET IT
Times cited: 17 -
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study.
European Journal of Cancer.
2012
Academic Article
GET IT
Times cited: 87